Efficacy and Safety of Irbesartan/Amlodipine Fixed Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy.

Trial Profile

Efficacy and Safety of Irbesartan/Amlodipine Fixed Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy.

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Jul 2012

At a glance

  • Drugs Amlodipine/irbesartan (Primary) ; Irbesartan
  • Indications Essential hypertension
  • Focus Registrational; Therapeutic Use
  • Acronyms I-ADD
  • Most Recent Events

    • 30 Jul 2012 Results published in Clinical Therapeutics.
    • 20 Jun 2011 Results presented at the 21st European Meeting on Hypertension.
    • 24 May 2011 Results presented at the 26th Annual Scientific Meeting of the American Society of Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top